Vaccine against pancreatic cancer
A professor at the University of Oslo has developed a cancer vaccine that can prolong the life expectancy of patients with pancreatic cancer. Now he is testing a new vaccine that hopefully is able to kill all types of cancer cells.
Photo: Yngve Vogt, UiO
For the last 20 years, Gustav Gaudernack, the Emeritus Professor at the Institute of Cancer Research at the University of Oslo (UiO), has researched into various vaccines against pancreatic cancer. This is one of the cancers with the highest mortality rate and lowest survival rate. The average life-time after surgery is only 18 months.
Read the whole story in Apollon, University of Oslo's popular scientific research magazine
Published Feb 1, 2012 12:17 PM
- Last modified Feb 20, 2012 01:02 PM